- DL Recommends: Moderate Sell
- This is recommended as Moderate sell as this stock is expected to do slightly worse than the overall stock market return.
Key Fundamentals of SUN PHARMACEUTICALS INDUSTRIES
- Sector:
- PHARMA
- Category:
- Large Cap
Profit after Tax | 2665.42 | Book Value | 186.40 |
PE Ratio | 40.42 | Institutions Holding | 707 |
Market Capitalization | 107742.14 | ||
Debt to Equity Ratio | 0.24 | EBIDTA | 4554.34 |
Dividend Yield | 0.61 | Promoter's Pledge (%) | 10.41 |
Correction Levels to Buy(From recent high)
Recent High | 931.30 |
10% Correction | - |
20% Correction | - |
30 % Correction | - |
Strong Support Technical Buy Levels(Monthly & Weekly Levels)
Week 3 Level | 443.10 |
Week 4 Level | 388.30 |
Chart
We recomend to use Weekly and Monthly charts. Daily charts are also given which are used for exits. We donot recomend daily/intraday minuite, hourly charts. The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit exit.
Exchange Symbol | SUNPHARMA (NSE) |
---|---|
Sector | PHARMA |
Current Price * (Rs.) | 835.80 |
Face Value (Rs.) | 1 |
52 Week High (Rs.) | 484.25 (01-Apr-19) |
52 Week Low (Rs.) | 344.55 (13-May-19) |
Life Time high (Rs.) | 1200.80 (07-Apr-15) |
Life Time low (Rs.) | 1.65 (22-Nov-96) |
Average Daily Movement [ADM] | 21.82 |
Average Volume [20 days] | 2566466 |
Average Value [1 Year] | 306.98 (Cr) |
1 Month Return (%) | 3.19 |
Consolidated FY 15-16 PE Ratio | 40.42 |
Consolidated Trailing PE Ratio | 24.87 |
Standalone FY 15-16 PE Ratio | 131.94 |
Standalone Trailing PE Ratio | 41.16 |
Book Value | 186.40 |
Market Cap | 107742.14 (Cr) |
% of Promoter holding pledged | 10.41 |
Get to know the SUN PHARMA share price & overview of SUN PHARMA, 52 week highs/lows & lifetime highs/lows, average volume, adm & 1 month return %.